IMO he waits for very definite, high impact results (mid Feb-end of Mar IMO) to have a PR -in baseball terms - that is the mother of all Grand Slams instead of a solid double or triple.  Just don't see at this time how the data could be that awe inspiring.

Disclaimer:  This opinion is coming from a background with NO biotech experience or knowledge.